NewAmsterdam Pharma Corporation · 6 hours ago
Senior Manager, Quality Assurance
Maximize your interview chances
BiotechnologyLife Science
Insider Connection @NewAmsterdam Pharma Corporation
Get 3x more responses when you reach out via email instead of LinkedIn.
Responsibilities
Provide GxP (GMP, GCP, GLP, GVP) support to cross functional teams
Ensure compliance with all applicable global GxP regulations and guidelines
Manage QA for products in phase 2 and late phase 3 pre-validation and commercialization
Develop, review and approve GxP controlled documents, such as: Policies, Standard Operating Procedures (SOPs), Work Instructions, and supporting documents related to GxP activities
Ensure quality systems, processes, specifications, and SOPs are appropriate for clinical manufacturing, release and distribution of quality product meeting relevant regulatory requirements, applicable standards and guidance
Assist in phase appropriate oversight of systems and optimize systems as they move from late phase 3 to commercial phases
Assist in maintenance of internal tracking and management of processes overseeing deviations, CAPA, change controls, document changes, temperature excursions, and others as assigned.
Assist in coordination and conduct of routine and non-routine quality assurance audits including: CMOs/vendors, process, system, and document reviews to assure quality assurance with regard to all internal procedures as well as regulatory guidelines; this will include conducting audits
Participate in internal audits to identify areas of improvement and collaborate with stakeholders to implement effective and sustainable corrective measures
Act as a liaison with quality counterpart at CMOs/vendors
Establish and maintain quality oversight of CMOs/vendors including participating in design and execution of vendor assessments, establishing/monitoring compliance to Quality Agreements
Conduct Quality review of vendor master and executed batch records, stability protocols, validation protocols/reports and analytical protocols, methods and reports
Conduct product release of drug substance, drug product, packaged and labeled product
Assist in evaluation and proactive escalation (as appropriate) of product quality issues. Ensure timely and effective follow-up of all identified or assigned quality issues
Provide quality support to internal and external change controls assessing product quality and regulatory impact
Provide quality support for deviations, complaint investigations, and OOS/OOTs, assessing for product quality and program impact. Partner with internal and external stakeholders to drive issue resolution, CAPA identification and ensure timely closure
Review and verify data to ensure compliance with data integrity and regulatory requirements, as appropriate
Support preparation of CMC investigational and commercial regulatory submissions by reviewing and approving relevant documents per program timelines and associated Health Authority (HA) information requests, as required
Support related activities in preparation for HA inspections and support interactions during HA inspections
Assist in generation, tracking and trending of Quality System compliance metrics and compile metrics and information for quality reporting
Qualification
Find out how your skills align with this job's requirements. If anything seems off, you can easily click on the tags to select or unselect skills to reflect your actual expertise.
Required
Bachelor's degree in a scientific discipline, advanced degree a plus
7+ years in the pharmaceutical industry, with a minimum of 5 years in Quality Assurance
Solid understanding of GxP standards, policies, and procedures (domestic and international)
Excellent verbal and written communication skills
Collaborative problem-solver, ability to analyze complex issues to develop relevant and realistic plans, programs, and recommendations
Ability to continuously re-prioritize and work independently, as a member of a cross-functional team, and with external vendors with minimal supervision
Ability to travel domestically and internationally, approx. 10-15% of the time
Preferred
Experience moving from late phase 3 into commercialization
Experience and understanding of small molecule drug substance and non-sterile solid oral dosage drug product manufacturing
Benefits
Health insurance
Dental and vision coverage
Term life and disability coverage
Retirement plans
Stock option awards
Company
NewAmsterdam Pharma Corporation
This page is intended for US audiences.
Funding
Current Stage
Public CompanyTotal Funding
$786.27M2024-02-13Post Ipo Equity· $175.3M
2023-06-06Post Ipo Secondary· $181.56M
2022-11-23Post Ipo Equity· $235M
Recent News
2024-05-04
Google Patent
2024-04-14
Company data provided by crunchbase